These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 27650914)

  • 1. A mathematical model of osteoclast acidification during bone resorption.
    Marcoline FV; Ishida Y; Mindell JA; Nayak S; Grabe M
    Bone; 2016 Dec; 93():167-180. PubMed ID: 27650914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoclastic acidification pathways during bone resorption.
    Rousselle AV; Heymann D
    Bone; 2002 Apr; 30(4):533-40. PubMed ID: 11934642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ion transporters involved in acidification of the resorption lacuna in osteoclasts.
    Henriksen K; Sørensen MG; Jensen VK; Dziegiel MH; Nosjean O; Karsdal MA
    Calcif Tissue Int; 2008 Sep; 83(3):230-42. PubMed ID: 18787885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of acid flux in osteoclasts from patients harboring a G215R mutation in ClC-7.
    Henriksen K; Gram J; Neutzsky-Wulff AV; Jensen VK; Dziegiel MH; Bollerslev J; Karsdal MA
    Biochem Biophys Res Commun; 2009 Jan; 378(4):804-9. PubMed ID: 19070589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diphyllin, a novel and naturally potent V-ATPase inhibitor, abrogates acidification of the osteoclastic resorption lacunae and bone resorption.
    Sørensen MG; Henriksen K; Neutzsky-Wulff AV; Dziegiel MH; Karsdal MA
    J Bone Miner Res; 2007 Oct; 22(10):1640-8. PubMed ID: 17576165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degradation of the organic phase of bone by osteoclasts: a secondary role for lysosomal acidification.
    Henriksen K; Sørensen MG; Nielsen RH; Gram J; Schaller S; Dziegiel MH; Everts V; Bollerslev J; Karsdal MA
    J Bone Miner Res; 2006 Jan; 21(1):58-66. PubMed ID: 16355274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cooperative electrogenic proton transport pathways in the plasma membrane of the proton-secreting osteoclast.
    Kuno M
    Pflugers Arch; 2018 Jun; 470(6):851-866. PubMed ID: 29550927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoclastic acid transport: mechanism and implications for physiological and pharmacological regulation.
    Schlesinger PH; Mattsson JP; Blair HC
    Miner Electrolyte Metab; 1994; 20(1-2):31-9. PubMed ID: 8202050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. V-ATPase subunit ATP6AP1 (Ac45) regulates osteoclast differentiation, extracellular acidification, lysosomal trafficking, and protease exocytosis in osteoclast-mediated bone resorption.
    Yang DQ; Feng S; Chen W; Zhao H; Paulson C; Li YP
    J Bone Miner Res; 2012 Aug; 27(8):1695-707. PubMed ID: 22467241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone resorption inhibitor alendronate normalizes the reduced bone thickness of TRPV5(-/-) mice.
    Nijenhuis T; van der Eerden BC; Hoenderop JG; Weinans H; van Leeuwen JP; Bindels RJ
    J Bone Miner Res; 2008 Nov; 23(11):1815-24. PubMed ID: 18597625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoplasmic pH regulation and chloride/bicarbonate exchange in avian osteoclasts.
    Teti A; Blair HC; Teitelbaum SL; Kahn AJ; Koziol C; Konsek J; Zambonin-Zallone A; Schlesinger PH
    J Clin Invest; 1989 Jan; 83(1):227-33. PubMed ID: 2910910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acid-inducible proton influx currents in the plasma membrane of murine osteoclast-like cells.
    Kuno M; Li G; Moriura Y; Hino Y; Kawawaki J; Sakai H
    Pflugers Arch; 2016 May; 468(5):837-47. PubMed ID: 26843093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular ClC-3 chloride channels promote bone resorption in vitro through organelle acidification in mouse osteoclasts.
    Okamoto F; Kajiya H; Toh K; Uchida S; Yoshikawa M; Sasaki S; Kido MA; Tanaka T; Okabe K
    Am J Physiol Cell Physiol; 2008 Mar; 294(3):C693-701. PubMed ID: 18234851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ion channels and transporters in osteoclasts.
    Supanchart C; Kornak U
    Arch Biochem Biophys; 2008 May; 473(2):161-5. PubMed ID: 18406337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification.
    Li YP; Chen W; Liang Y; Li E; Stashenko P
    Nat Genet; 1999 Dec; 23(4):447-51. PubMed ID: 10581033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of bone resorption by the osteoclast.
    Baron R
    Anat Rec; 1989 Jun; 224(2):317-24. PubMed ID: 2549811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane-bound carbonic anhydrases in osteoclasts.
    Riihonen R; Supuran CT; Parkkila S; Pastorekova S; Väänänen HK; Laitala-Leinonen T
    Bone; 2007 Apr; 40(4):1021-31. PubMed ID: 17291844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The bisphosphonate tiludronate is a potent inhibitor of the osteoclast vacuolar H(+)-ATPase.
    David P; Nguyen H; Barbier A; Baron R
    J Bone Miner Res; 1996 Oct; 11(10):1498-507. PubMed ID: 8889850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Cl-/H+ antiporter ClC-7 is the primary chloride permeation pathway in lysosomes.
    Graves AR; Curran PK; Smith CL; Mindell JA
    Nature; 2008 Jun; 453(7196):788-92. PubMed ID: 18449189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atp6v0d2 is an essential component of the osteoclast-specific proton pump that mediates extracellular acidification in bone resorption.
    Wu H; Xu G; Li YP
    J Bone Miner Res; 2009 May; 24(5):871-85. PubMed ID: 19113919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.